Maverick Capital Ltd. Cuts Stock Position in Smartstop Self Storage REIT Inc $SMA

Maverick Capital Ltd. trimmed its position in shares of Smartstop Self Storage REIT Inc (NYSE:SMA) by 85.8% in the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund owned 22,583 shares of the healthcare company’s stock after selling 136,980 shares during the quarter. Maverick Capital Ltd.’s holdings in Smartstop Self Storage REIT were worth $684,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the company. JPMorgan Chase & Co. purchased a new stake in shares of Smartstop Self Storage REIT during the 2nd quarter valued at $3,155,000. New York State Common Retirement Fund purchased a new position in Smartstop Self Storage REIT during the 2nd quarter worth $326,000. Quantbot Technologies LP purchased a new position in Smartstop Self Storage REIT during the 2nd quarter worth $377,000. Invesco Ltd. acquired a new position in Smartstop Self Storage REIT during the 2nd quarter valued at about $602,000. Finally, Marshall Wace LLP purchased a new stake in Smartstop Self Storage REIT in the second quarter valued at about $830,000.

Analysts Set New Price Targets

Several equities research analysts have weighed in on the company. Raymond James Financial assumed coverage on Smartstop Self Storage REIT in a report on Wednesday, July 15th. They issued a “strong-buy” rating and a $39.00 price target for the company. Wells Fargo & Company restated a “neutral” rating on shares of Smartstop Self Storage REIT in a report on Friday. Zacks Research raised shares of Smartstop Self Storage REIT from a “strong sell” rating to a “hold” rating in a research report on Friday, May 8th. Finally, Weiss Ratings upgraded shares of Smartstop Self Storage REIT from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, July 16th. Two investment analysts have rated the stock with a Strong Buy rating, four have given a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, Smartstop Self Storage REIT currently has a consensus rating of “Moderate Buy” and an average price target of $36.44.

Smartstop Self Storage REIT Price Performance

Shares of NYSE:SMA opened at $35.43 on Wednesday. Smartstop Self Storage REIT Inc has a twelve month low of $29.41 and a twelve month high of $39.77. The company has a current ratio of 5.33, a quick ratio of 5.33 and a debt-to-equity ratio of 0.86. The company has a market cap of $1.96 billion, a PE ratio of 236.21 and a beta of 0.56. The company’s 50 day moving average is $32.59 and its 200 day moving average is $32.21.

Smartstop Self Storage REIT (NYSE:SMA) last announced its quarterly earnings data on Wednesday, May 6th. The healthcare company reported $0.49 EPS for the quarter, beating the consensus estimate of $0.48 by $0.01. The business had revenue of $78.31 million during the quarter, compared to analysts’ expectations of $72.56 million. Smartstop Self Storage REIT had a net margin of 4.38% and a return on equity of 1.00%. The firm’s revenue was up 19.7% on a year-over-year basis. Smartstop Self Storage REIT has set its FY 2026 guidance at 1.940-2.040 EPS. On average, sell-side analysts forecast that Smartstop Self Storage REIT Inc will post 2 EPS for the current year.

Smartstop Self Storage REIT Increases Dividend

The firm also recently announced a monthly dividend, which will be paid on Friday, August 14th. Investors of record on Friday, July 31st will be given a dividend of $0.1359 per share. This is a boost from Smartstop Self Storage REIT’s previous monthly dividend of $0.13. This represents a c) dividend on an annualized basis and a yield of 4.6%. The ex-dividend date is Friday, July 31st. Smartstop Self Storage REIT’s payout ratio is presently 1,053.33%.

About Smartstop Self Storage REIT

Symmetry Medical Inc (Symmetry) is a medical device solutions company, including surgical instruments, orthopedic implants, and sterilization cases and trays. The Company designs, develops and offers worldwide production and supply chain capabilities for these products to customers in the orthopedic industry, and other medical device markets (including but not limited to arthroscopy, dental, laparoscopy, osteobiologic, and endoscopy segments). It also manufactures specialized non-healthcare products, primarily in the aerospace industry.